Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 6.4 SEK -1.54% Market Closed
Market Cap: 1.5B SEK

Intrinsic Value

VICO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one VICO stock under the Base Case scenario is 3.92 SEK. Compared to the current market price of 6.4 SEK, Vicore Pharma Holding AB is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VICO Intrinsic Value
3.92 SEK
Overvaluation 39%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Vicore Pharma Holding AB

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
VICO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for VICO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Vicore Pharma Holding AB
STO:VICO
SE
Biotechnology
Market Cap
1.5B SEK
IPO
Dec 10, 2015
SE
Biotechnology
Market Cap
1.5B SEK
IPO
Dec 10, 2015
Price
krfalse
EPS
krfalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VICO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Vicore Pharma Holding AB
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vicore Pharma Holding AB

Current Assets 1.2B
Cash & Short-Term Investments 1.2B
Receivables 14.4m
Other Current Assets 32.7m
Efficiency

Free Cash Flow Analysis
Vicore Pharma Holding AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vicore Pharma Holding AB

Revenue
109.3m SEK
Operating Expenses
-303.5m SEK
Operating Income
-194.2m SEK
Other Expenses
25.6m SEK
Net Income
-168.6m SEK
Fundamental Scores

VICO Profitability Score
Profitability Due Diligence

Vicore Pharma Holding AB's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score

Vicore Pharma Holding AB's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

VICO Solvency Score
Solvency Due Diligence

Vicore Pharma Holding AB's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
69/100
Solvency
Score

Vicore Pharma Holding AB's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VICO Price Targets Summary
Vicore Pharma Holding AB

Wall Street analysts forecast VICO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VICO is 31.17 SEK with a low forecast of 15.15 SEK and a high forecast of 40.86 SEK.

Lowest
Price Target
15.15 SEK
137% Upside
Average
Price Target
31.17 SEK
387% Upside
Highest
Price Target
40.86 SEK
539% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Vicore Pharma Holding AB
does not pay dividends
Shareholder Yield

Current shareholder yield for VICO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VICO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VICO stock?

The intrinsic value of one VICO stock under the Base Case scenario is 3.92 SEK.

Is VICO stock undervalued or overvalued?

Compared to the current market price of 6.4 SEK, Vicore Pharma Holding AB is Overvalued by 39%.

Back to Top